Month 1
$299
1 mL vial · 20 mg/mL
Dosing
0.20 mL × 4 weeks = 0.80 mL
- Leaves 0.20 mL (20 units) carried into Month 2.
Tirzepatide Program
Dual GIP/GLP-1 agonism. Drive metabolic shift.
3-month dose-escalating protocol
Starts at $299 / month
Tirzepatide engages both GIP and GLP-1 receptors to orchestrate a comprehensive metabolic response. By slowing gastric emptying and enhancing insulin secretion while reducing glucagon, it stabilizes blood glucose and curbs appetite. This three-month dose-escalating protocol, compounded with Vitamin B-6, supports sustained weight management through a structured, once-weekly subcutaneous regimen.
The protocol
3-month dose-escalating protocol
Month 2
$299
1 mL vial · 20 mg/mL
Dosing
0.30 mL × 4 weeks = 1.20 mL
- Includes 0.20 mL carry-over from Month 1.
Month 3
$350
2 mL vial · 20 mg/mL
Dosing
0.50 mL × 4 weeks = 2.00 mL
Months 4–5 at $350 / vial if your clinician escalates further.
- All vials contain 1.25 mg/mL B-6.
Pricing subject to change. Final dose and eligibility confirmed by a licensed clinician after intake.